TY - JOUR KW - AIDS-Related Opportunistic Infections KW - Antiretroviral Therapy, Highly Active KW - Epidemiologic Methods KW - Female KW - French Guiana KW - HIV Infections KW - Humans KW - Immune Reconstitution Inflammatory Syndrome KW - leprosy KW - Male AU - CouppiƩ P AU - Domergue V AU - Clyti E AU - El Guedj M AU - Vaz T AU - Sainte-Marie D AU - Marty C AU - Nacher M AB -

A retrospective cohort study was conducted to determine whether the incidence of leprosy varied with the duration of antiretroviral therapy (ART). Between 1992 and 2006, seven cases of leprosy were observed. The incidence of leprosy in untreated patients was 0.7 per 1000 person-years, 13 per 1000 person-years in persons receiving HAART for more than 3 months and 0.9 per 1000 person-years for persons receiving HAART for more than 3 months. The adjusted hazard ratio was 18.5 (95% confidence interval, 1.6-217) with P = 0.02. In tropical areas where HAART is increasingly available, physicians should be aware of the possibility of incident leprosy shortly after HAART initiation.

BT - AIDS (London, England) C1 - http://www.ncbi.nlm.nih.gov/pubmed/19487911?dopt=Abstract DA - 2009 Jul 31 DO - 10.1097/QAD.0b013e32832bb5b7 IS - 12 J2 - AIDS LA - eng N2 -

A retrospective cohort study was conducted to determine whether the incidence of leprosy varied with the duration of antiretroviral therapy (ART). Between 1992 and 2006, seven cases of leprosy were observed. The incidence of leprosy in untreated patients was 0.7 per 1000 person-years, 13 per 1000 person-years in persons receiving HAART for more than 3 months and 0.9 per 1000 person-years for persons receiving HAART for more than 3 months. The adjusted hazard ratio was 18.5 (95% confidence interval, 1.6-217) with P = 0.02. In tropical areas where HAART is increasingly available, physicians should be aware of the possibility of incident leprosy shortly after HAART initiation.

PY - 2009 SP - 1599 EP - 600 T2 - AIDS (London, England) TI - Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease. VL - 23 SN - 1473-5571 ER -